Free Trial
NASDAQ:CAPS

Capstone Therapeutics (CAPS) Stock Price, News & Analysis

Capstone Therapeutics logo
$1.44 -0.22 (-13.25%)
As of 08/1/2025 04:00 PM Eastern

About Capstone Therapeutics Stock (NASDAQ:CAPS)

Key Stats

Today's Range
$1.29
$1.69
50-Day Range
$1.36
$1.94
52-Week Range
$1.29
$16.18
Volume
177,609 shs
Average Volume
90,559 shs
Market Capitalization
$230.40 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CAPS Stock News Headlines

Michael Parker
One stock to replace Nvidia
I'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce competitors, dethroning the AI Chip King. But there's a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry's "Nvidia-killer" stock ideas.
A capstone project
Capstone Holding Corp. (J7W.F)
See More Headlines

CAPS Stock Analysis - Frequently Asked Questions

Capstone Therapeutics' stock was trading at $2.40 on January 1st, 2025. Since then, CAPS shares have decreased by 40.0% and is now trading at $1.44.

Capstone Therapeutics (CAPS) raised $5 million in an initial public offering (IPO) on Thursday, March 6th 2025. The company issued 1,250,000 shares at $4.00 per share.

Capstone Therapeutics's lock-up period expires on Tuesday, September 2nd. Capstone Therapeutics had issued 1,250,000 shares in its initial public offering on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CAPS
CIK
887151
Web
N/A
Employees
38
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
1.14
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$44.88 million
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($19.40) per share
Price / Book
-0.07

Miscellaneous

Outstanding Shares
160,000
Free Float
90,000
Market Cap
$230.40 thousand
Optionable
N/A
Beta
-0.80
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CAPS) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners